Symposium

Behavioral Health Services

Brain Injury

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

Second Annual Biomarker & Biometrics Blitz Review!

Wednesday, November 9, 2022

4:45 PM – 6:00 PM

Presenter(s)

Janet P. Niemeier, PhD, ABPP (RP)

Private Practice, Adjunct Associate Professor UAB
Ackerson & Associates, University of Alabama
Vestavia Hills, Alabama, United States

Slides Slides and Audio
Amy A. Herrold, PhD, RYT

Research Health Scientist & Research Associate Professor
Edward Hines Jr., VA Hospital & Northwestern University
Hines, Illinois, United States
Patricia C. Heyn, PhD, FGSA, FACRM (she/her/hers)

Founding Director Center for Optimal Aging
Marymount University
Arlington, Virginia, United States
Caroline Schnakers, PhD

Assistant Director
Casa Colina Hospital and Centers for Healthcare
Pomona, California, United States

Slides Slides and Audio
Chih-Ying Li, PhD, OTR

Associate Professor
University of Texas Medical Branch
Galveston, Texas, United States

Slides Slides and Audio
Pey-Shan Wen, MHS, PHD, OTR/L

Associate professor
Georgia State University
Atlanta, Georgia, United States
Julie L. Schwertfeger, PhD

Advanced Polytrauma / TBI Research Fellow, VA; Adjunct Assistant Professor, Chicago Medical School
Captain James A. Lovell FHCC, Rosalind Franklin University of Medicine & Science
Lombard, Illinois, United States

Slides

A rapid-fire, second annual presentation by the Measurement Special Interest Group Biomarkers and Biometrics Task Force members to update scientists, researchers, and clinicians on value of multimodal biomarkers in rehabilitation research and medicine.

Learning Objectives:

Upon completion, participant will be able to list and describe several different types of biomarkers that have been and can be used in combination for increased precision of measurement in ABI and TBI research.
Upon completion participants will be able to discuss and describe several domains of brain injury research with enhanced findings when using multimodal biomarkers.
Upon completion, participants will be able to discuss key preliminary findings of a scoping review of multimodal biomarkers in use with TBI and ABI research.
Upon completion, participants will be able to describe information and potential research foci from a case series looking at symptoms and outcomes of Long-COVID patients with ADHD/concussion/TBI/substance misuse history.